Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
empagliflozin
1245.31
NCT01289990
Diabetes Mellitus, Type 2
Phase 3
 
February 2016

Powered by ideaPoint, Inc.